These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42 related articles for article (PubMed ID: 1398464)
21. Effect of subcutaneous injection of a long-acting analogue of somatostatin (SMS 201-995) on plasma thyroid-stimulating hormone in normal human subjects. Itoh S; Tanaka K; Kumagae M; Takeda F; Morio K; Kogure M; Hasegawa M; Horiuchi T; Watabe T; Miyabe S Life Sci; 1988; 42(26):2691-9. PubMed ID: 2898717 [TBL] [Abstract][Full Text] [Related]
22. Postprandial gallbladder motility during long term treatment with the long-acting somatostatin analog SMS 201-995 in acromegaly. van Liessum PA; Hopman WP; Pieters GF; Jansen JB; Smals AG; Rosenbusch G; Kloppenborg PW; Lamers CB J Clin Endocrinol Metab; 1989 Sep; 69(3):557-62. PubMed ID: 2760170 [TBL] [Abstract][Full Text] [Related]
23. Postprandial exocrine pancreatic function during long-term treatment with the somatostatin analogue SMS 201-995 in acromegalic patients. Van Liessum PA; Hopman WP; Pieters GF; Smals AG; Tangerman A; Jansen JB; Rosenbusch G; Lamers CB Eur J Clin Invest; 1990 Aug; 20(4):348-53. PubMed ID: 2121494 [TBL] [Abstract][Full Text] [Related]
24. Chronic dopamine receptor stimulation using bromocriptine: failure to modify thyroid function. Köbberling J; Darragh A; Del Pozo E Clin Endocrinol (Oxf); 1979 Oct; 11(4):367-70. PubMed ID: 117954 [TBL] [Abstract][Full Text] [Related]